help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 6, 2007
Endocrinology, doi:10.1210/en.2007-0300
A more recent version of this article appeared on December 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/12/6040    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saitoh, O.
Right arrow Articles by Nagayama, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saitoh, O.
Right arrow Articles by Nagayama, Y.

Submitted on March 5, 2007
Accepted on August 30, 2007

CD8+CD122+ T Cells, a Newly Identified Regulatory T Subset, Negatively Regulate Graves' Hyperthyroidism in a Murine Model

Ohki Saitoh, Norio Abiru, Mami Nakahara, and Yuji Nagayama*

Department of Medical Gene Technology, Atomic Bomb Disease Institute (O.S., Y.N.), Division of Immunology, Endocrinology and Metabolism (N.A.), and Division of Clinical Pharmaceutics (M.N.), Department of Medical and Dental Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523 Japan

* To whom correspondence should be addressed. E-mail: nagayama{at}nagasaki-u.ac.jp.

Graves' disease is a thyroid-specific autoimmune disease mediated by stimulatory autoantibodies against the TSH receptor (TSHR). We have previously shown in our mouse model with adenovirus expressing the TSHR that antibody-mediated depletion of CD4+CD25+ regulatory T cells (Treg) enhances incidence and severity of hyperthyroidism in resistant and susceptible, respectively, mouse strains. These data indicate that balance between effector T cells and Treg is critical for disease development. This study was designed to evaluate the role played by recently identified another type of Treg, CD8+CD122+ T cells, in our mouse model to delineate the significance of different types of Treg in Graves' disease. Flow cytometry analysis showed that CD4+CD25+ and CD8+CD122+ T cells are distinct cell types, and anti-CD122 antibody effectively and selectively depleted CD8+CD122+ T cells. As for CD4+CD25+ Treg, CD8+CD122+ T cell depletion increased incidence of hyperthyroidism both in resistant and susceptible mice. Of interest, intrathyroidal lymphocytic infiltration was observed in some CD8+CD122+ T cell-depleted, hyperthyroid resistant mice. These results indicate that in addition to CD4+CD25+ T cells, CD8+CD122+ T cells also play a crucial role in disease susceptibility in mouse Graves' disease. Thus different types of Treg appear to be involved in tolerance to a self-antigen, the TSHR.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society